Home
Market Capitalization of Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Ltd
NSE: SENORES
Market Cap
Key Highlights
- The Market Cap of Senores Pharmaceuticals Ltd is ₹ 2538 crore as of 11 Mar 25 .
- The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 566.5 as of 12 Mar 10:02 .

Senores Pharmaceuticals Ltd
NSE: SENORES
Share Price
Market Price of Senores Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
11 Mar 2025 | 551.2 |
10 Mar 2025 | 548.75 |
07 Mar 2025 | 566.1 |
06 Mar 2025 | 593.75 |
05 Mar 2025 | 596.1 |
04 Mar 2025 | 562.2 |
03 Mar 2025 | 530.4 |
28 Feb 2025 | 543.75 |
27 Feb 2025 | 566.7 |
25 Feb 2025 | 548.55 |
BlinkX Score for Senores Pharmaceuticals Ltd
Asset Value vs Market Value of Senores Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Senores Pharmaceuticals Ltd
Historical P/E Ratio of Senores Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Senores Pharmaceuticals Ltd
Historical Revenue of Senores Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Senores Pharmaceuticals Ltd
Historical EBITDA of Senores Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Senores Pharmaceuticals Ltd
Historical Net Profit of Senores Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Senores Pharmaceuticals Ltd
Dividend Payout Over Time
About Senores Pharmaceuticals Ltd
- Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
- Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
- The Regulated Markets business is focused on Regulated Markets of US and Canada.
- The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.
Senores Pharmaceuticals Ltd News Hub
Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25
Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror
Read more
23 Jan 25
Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets
Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,
Read more
10 Jan 25
Senores Pharmaceuticals IPO subscribed 93.41 times
The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a
Read more
24 Dec 24
Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet
Senores Pharmaceuticals has received final approval from the United States Food and Drug Administrat
Read more
10 Jan 25